SOD1 and COVID-19: Serum SOD may be used as a biomarker for the prognosis of COVID-19, Mehri et al. (2021) found that the intensive care unit (ICU) COVID-19 patients exhibited higher SOD than non-ICU and healthy controls (HCs).